CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
LCPUFA supplement +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01955044
NCT01955044N/ACompleted
CompareCT.gov

Early DHA Supplementation in Extremely Low Birth Weight Infants

Endeavor Health·interventional·Posted Oct 7, 2013·Updated Sep 5, 2021

In Brief

A clinical study evaluating LCPUFA supplement and placebo for Premature, Extremely Low Birth Weight Infants and Polyunsaturated Fatty Acid Levels. Completed, enrolled 30 participants across 3 sites.

Detailed Summary

The purpose of this study is to determine if buccal administration of a concentrated formulation of long-chain polyunsaturated fatty acids (LCPUFA) can help to maintain docosahexaenoic acid (DHA) levels in extremely low birth weight (ELBW) infants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPremature, Extremely Low Birth Weight Infants, Polyunsaturated Fatty Acid Levels
CountriesUnited States
CollaboratorsAnn & Robert H Lurie Children's Hospital of Chicago, Northwestern University, Mead Johnson Nutrition

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 7, 2013
Enrollment StartSep 1, 2013
Primary CompletionApr 1, 2015
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 12.7 years ago

Interventions

LCPUFA supplementdietary

placebodietary